维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Chamoto k"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Liposome-Encapsttlated CpG Oligodeoxyuncleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity显示文摘	Wakita D Chamoto K	2004	Cancer Res2004，64，：	1
2	Local radiationtherapy inhibits tumor growth through the generation oftumor - specific CTL: its potentiation by combination withThl cell therapy 显示文摘	Takeshima T Chamoto K Wakita D	2010	Cancer Res2010，70，7：	1
3	Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio-and immuno-resistant lung carcinoma cells显示文摘	Chamoto K Takeshima T Wakita D		0，，05：	1
4	The critical role of type-1 innate and acquired immunity in tumor immunothcrapy 显示文摘	Ikcda H Chamoto K Tsuji T	2004	Canc-er Sci2004，95，：	1
5	Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity 显示文摘	Suzuki Y Wakita D Chamoto K	2004	Cancer Res2004，64，：	1
6	The critical of type-1 in-nate and acquired immunity in tumor immunotherapy显示文摘	Ikeda H Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1
7	The critical role of type- 1 innate and acquired immunity in tumor immunotherapy 显示文摘	Ikeda H Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1
8	Tetramer-blocking assay for defining antigen-spe cific cytotoxic T lymphocytes using peptide-MHC tetramer 显示文摘	Yokouchi H Chamoto K Wakita D	2006	Cancer Sci2006，97，2：	1
9	The critical roleof type-1 innate and acquired immunity in tumor im-munotherapy 显示文摘	Ikeda H’Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1
10	Liposome- encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing Type 1 innate immunity 显示文摘	Suzuki Y Wakita D Chamoto K	2004	Cancer Res2004，64，23：	1
11	IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model 显示文摘	Wakita D Chamoto K Ohkuri T	2009	Carcinogenesis2009，30，8：	1
12	The critical role of type--1 in- nate and acquired immunity in tumor immunotherapy 显示文摘	Ikeda H Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1
13	The critical role of type-1 innate and acquired immunity in tumor immunotherapy 显示文摘	Ikeda H Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1
14	The critical role of type-1 innateand acquired immunity in tumor immunotherapy显示文摘	Ikeda H Chamoto K Tsuji T		0，，09：	1
15	Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells显示文摘	Chamoto K Tsuji T Funamoto H	2004	Cancer Res2004，64，1：	1
16	IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model 显示文摘	Wakita D Chamoto K Ohkuri T	2009	Carci- nogenesis2009，30，8：	1
17	The critical role of type-1 innateand acquired immunity in tumor immunotherapy显示文摘	Ikeda H Chamoto K Tsuji T	2004	CancerScience2004，95，：	1
18	Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy显示文摘	Chamoto K Kosaka A Tsuji T	2003	Cancer Sci2003，94，10：	1
19	An indispensable role of type-Ⅰ IFNs for inducing CTL-mediated complete eradication of established tumor issue by CpG-liposome co-encapsulated with model tumor antigen显示文摘	Wakita D Chamoto K Zhang Y	2006	Int Immunol2006，18，3：	1
20	The critical role of type-1 innate and acquired immunity in tumor immunotherapy显示文摘	Ikeda H Chamoto K Tsuji T	2004	Cancer Sci2004，95，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示